Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer
Hidenori Kitai(Memorial Sloan Kettering Cancer Center), Neal Rosen(Memorial Sloan Kettering Cancer Center)
Cited by 31
Related Papers
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
|Cancer Research|2006|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
RETRACTED: Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling
|PLoS ONE|2008|317
Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma
|Cell Reports Medicine|2024|4
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2024|2